Trintellix (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Trintellix drug offered from Takeda Pharmaceuticals America, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
NON-PROPRIETARY NAME: | vortioxetine |
SUBSTANCE NAME: | VORTIOXETINE HYDROBROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-10-02 |
END MARKETING DATE: | 0000-00-00 |
Trintellix HUMAN PRESCRIPTION DRUG Details:
Item Description | Trintellix from Takeda Pharmaceuticals America, Inc. |
LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2013-10-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64764-720_fc117e75-5c73-4373-ad38-76b73bfc6073 |
PRODUCT NDC: | 64764-720 |
APPLICATION NUMBER: | NDA204447 |
Other VORTIOXETINE HYDROBROMIDE Pharmaceutical Manufacturers / Labelers: